New drug trial targets debilitating muscle disease
Disease control
Recruiting now
This study is testing an investigational drug called DYNE-101 for adults with myotonic dystrophy type 1 (DM1), a genetic disorder that causes progressive muscle weakness and stiffness. The main goals are to see if the drug is safe and if it can improve muscle function and reduce …
Phase: PHASE1, PHASE2 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC